← Leaderboards
Mark Gregory Luciano
Johns Hopkins University
$10,508,934
Attributed
$16,490,384
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,490,384 · 5
By mechanism
U01$11,962,900 · 1
R01$4,077,171 · 3
R21$450,313 · 1
Top collaborators
- Richard Holubkov7 shared
Others in their field
Top investigators on “Hydrocephalus”
- Jonathan Michael Dean · University Of Utah$12,397,835
- Guohua Xi · University Of Michigan At Ann Arbor$8,558,783
- Elizabeth A Thom · George Washington University$8,349,507
- Sandra E Juul · University Of Florida$8,258,709
- Richard Holubkov · Johns Hopkins University$8,109,758
- N Scott Adzick · Children'S Hospital Of Philadelphia$7,006,195
Research focus
HydrocephalusAnatomyOperative Surgical ProceduresSuccessMagnetic Resonance ImagingCostPhysiologicalCerebrospinal FluidImageLiquid SubstanceBiological MarkersSymptomsPersonsDiagnosisCerebrospinal Fluid Shunts ProcedureBrainPatternEquilibriumCephalicAffectExcisionAlzheimer&AposFluid FlowDementia
Grant awards (18)
A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial$2,237,103
U01 · FY2025 · NS · contact PI
A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial$15,612
U01 · FY2025 · NS · contact PI
A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial$8,605
U01 · FY2025 · NS · contact PI
A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial$1,771
U01 · FY2025 · NS · contact PI
A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial$3,266,140
U01 · FY2024 · NS · contact PI
Establishing a Novel Neural Tissue Deformation Biomarker for Type 1 Chiari Malformation$348,854
R01 · FY2023 · NS · contact PI
A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial$3,378,298
U01 · FY2022 · NS · contact PI
Establishing a Novel Neural Tissue Deformation Biomarker for Type 1 Chiari Malformation$389,693
R01 · FY2022 · NS · contact PI
A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial$3,055,371
U01 · FY2021 · NS · contact PI
Establishing a Novel Neural Tissue Deformation Biomarker for Type 1 Chiari Malformation$431,578
R01 · FY2021 · NS · contact PI
A study of paravascular and interstitial flow in Hydrocephalus and shunting$204,688
R21 · FY2021 · NS · contact PI
A study of paravascular and interstitial flow in Hydrocephalus and shunting$245,625
R21 · FY2020 · NS · contact PI
Improving CBF through direct control of CSF pulsations$709,536
R01 · FY2010 · NS · contact PI
Improving CBF through direct control of CSF pulsations$799,298
R01 · FY2009 · NS · contact PI
Cerebral Blood Flow Response to Chronic Hydrocephalus$344,250
R01 · FY2004 · NS
Cerebral Blood Flow Response to Chronic Hydrocephalus$344,250
R01 · FY2003 · NS
Cerebral Blood Flow Response to Chronic Hydrocephalus$356,992
R01 · FY2002 · NS
Cerebral Blood Flow Response to Chronic Hydrocephalus$352,720
R01 · FY2001 · NS